EWC vs XBI
iShares MSCI Canada ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.50% for EWC.
- • EWC pays a higher dividend yield (1.30%).
Side-by-side metrics
| Metric | EWC | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.50% | 0.35% |
Dividend yield Trailing 12-month yield. | 1.30% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $5.96B | $10.73B |
YTD return | 7.99% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.80 | 1.10 |
P/E ratio | 21.00 | — |
Last price | $58.49 | $164.01 |
Inception | — | — |
Issuer | iShares | State Street |
EWC top holdings
| RY | Royal Bank of Canada | 9.68% |
| TD | The Toronto-Dominion Bank | 6.74% |
| SHOP | Shopify Inc Registered Shs -A- Subord Vtg | 4.69% |
| BMO.TO | Bank of Montreal | 4.07% |
| ENB.TO | Enbridge Inc | 3.96% |
| BNS.TO | Bank of Nova Scotia | 3.59% |
| CM.TO | Canadian Imperial Bank of Commerce | 3.54% |
| BN.TO | Brookfield Corp Registered Shs -A- Limited Vtg | 2.85% |
| CNQ.TO | Canadian Natural Resources Ltd | 2.76% |
| AEM.TO | Agnico Eagle Mines Ltd | 2.64% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About EWC
EWC (iShares MSCI Canada ETF) is Canadian large and mid-cap equities. Managed by iShares, the fund carries $6.0B in assets under management, an expense ratio of 0.50%, a dividend yield of 1.30%. Its largest holding is Royal Bank of Canada (RY), which represents 9.7% of the portfolio. Real Estate is the fund's largest sector exposure at 0.2%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.